HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 604 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,458,832 | +11.7% | 47,185 | -0.7% | 0.01% | +20.0% |
| Q2 2023 | $4,888,011 | +11.7% | 47,517 | +18.5% | 0.01% | 0.0% |
| Q1 2023 | $4,375,204 | -16.3% | 40,088 | -12.7% | 0.01% | -28.6% |
| Q4 2022 | $5,224,900 | +3.8% | 45,913 | -43.6% | 0.01% | 0.0% |
| Q3 2022 | $5,034,000 | -72.1% | 81,335 | -52.5% | 0.01% | -26.3% |
| Q1 2022 | $18,016,000 | +96.5% | 171,228 | +101.3% | 0.02% | -5.0% |
| Q4 2021 | $9,168,000 | +1075.4% | 85,076 | +1093.7% | 0.02% | +900.0% |
| Q3 2021 | $780,000 | -48.1% | 7,127 | -55.6% | 0.00% | -50.0% |
| Q2 2021 | $1,503,000 | +225.3% | 16,046 | +219.6% | 0.00% | +100.0% |
| Q1 2021 | $462,000 | +32.8% | 5,020 | +5.5% | 0.00% | +100.0% |
| Q4 2020 | $348,000 | +1.8% | 4,757 | +8.1% | 0.00% | -50.0% |
| Q3 2020 | $342,000 | – | 4,402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |